Novolin Injection, Suspension
Product Images NDC 50090-0403

31 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Novolin (NDC 50090-0403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Human Insulin (Image 01)

Structural Formula Of Human Insulin (Image 01)
Chemical structure diagram illustrating the amino acid sequences of the A-chain and B-chain of human insulin, showing the arrangement of residues and disulfide bonds.*
FDA Label Image

Exclamation Point (Image 12)

Exclamation Point (Image 12)
The image shows a vial of Novolin 70/30 Human Insulin Injection, Suspension, labeled with 100 [iU]/mL strength. The vial has a purple cap and contains 10 mL of solution. The label includes the product name, concentration, and volume. The labeler is A-S Medication Solutions.*
FDA Label Image

Novolin 70/30 Flexpen Components (Image 13)

Novolin 70/30 Flexpen Components (Image 13)
Illustration of the Novolin 70/30 FlexPen insulin injection device showing its components including the pen cap, rubber stopper, glass cartridge with 12 units, cartridge scale, dose pointer selector, and push button. The pen is designed for subcutaneous injection of human insulin suspension.*
FDA Label Image

Needle Components (Image 14)

Needle Components (Image 14)
Illustration showing components of three different types of NovoFine needles for insulin injection: NovoFine, NovoFine Plus, and NovoTwist. Each type is depicted with its big outer needle cap, inner needle cap, needle, and protective tab arranged horizontally.*
FDA Label Image

Pull Off The Pen Cap. (Image 15)

Pull Off The Pen Cap. (Image 15)
An instructional illustration depicting a close-up of fingers holding and pushing a plunger-like component of a medical syringe or injection device, indicating an action of pulling or pushing the plunger to prepare or administer the injection.*
FDA Label Image

Move Pen Up And Down. (Image 16)

Move Pen Up And Down. (Image 16)
Instructional diagram showing a two-step arm movement for subcutaneous injection: step 1 is raising the bent arm upward with a vertical orientation; step 2 is lowering the forearm downward to a horizontal or downward position, demonstrating the injection technique for subcutaneous administration.*
FDA Label Image

Exclamation Point. (Image 17)

Exclamation Point. (Image 17)
Novolin 70/30 Human Insulin 100 IU/mL injection suspension carton from A-S Medication Solutions. The label includes the product name, concentration, and dosage form. The packaging is a rectangular box with predominantly white and blue colors, displaying the manufacturer and product details clearly.*
FDA Label Image

Screw The Needle On. (Image 18)

Screw The Needle On. (Image 18)
An instructional illustration showing how to prepare a NovoFine or NovoFine Plus needle and NovoTwist needle for injection. The two-panel image demonstrates removing needle covers or caps from the injection needle device. The diagrams use arrows to indicate the direction of removal, focusing on hands interacting with the needle components.*
FDA Label Image

Pull Off The Big Outer Needle Cap. (Image 19)

Pull Off The Big Outer Needle Cap. (Image 19)
Instructional illustration showing the steps to connect the NovoFine or NovoFine Plus needle and the NovoTwist needle to an injector device. Arrows indicate the direction of attachment for the subcutaneous injection preparation.*
FDA Label Image

Pull Off Inner Needle Cap. (Image 20)

Pull Off Inner Needle Cap. (Image 20)
Instructional illustration showing how to connect or twist a needle or device, labeled for NovoFine, NovoFine Plus, and NovoTwist products. The left panel depicts an arrow indicating insertion or alignment, while the right panel shows a twisting motion with an arrow, demonstrating the attachment process for injection use.*
FDA Label Image

Exclamation Point. (Image 24)

Exclamation Point. (Image 24)
Novolin 70/30 Human Insulin injection, suspension 100 IU/mL, in a vial. The label shows a clear vial with a white cap and black text. The product is labeled for subcutaneous use and manufactured by A-S Medication Solutions. The vial contains 10 mL of insulin suspension.*
FDA Label Image

Exclamation Point. (Image 25)

Exclamation Point. (Image 25)
The image shows the vial label for Novolin 70/30, a human insulin injection suspension containing 100 IU/mL. The label includes product name, concentration, route of administration as subcutaneous, and the A-S Medication Solutions as the labeler. The vial has a red cap and measurement markings.*
FDA Label Image

Exclamation Point. (Image 26)

Exclamation Point. (Image 26)
Novolin 70/30 human insulin injection 100 IU/mL label by A-S Medication Solutions. The label includes dosing information, usage instructions, and dispensing details for the subcutaneous suspension. The label is primarily blue-themed with identifiable brand and product names.*
FDA Label Image

Turn The Dose Selector. (Image 21)

Turn The Dose Selector. (Image 21)
An instructional illustration showing a close-up of a hand adjusting a dial on an injection pen. The dial indicates that 2 units are selected, demonstrating dose selection on the device, likely for Novolin 70/30 Human Insulin injection.*
FDA Label Image

Tap The Cartridge Gently. (Image 22)

Tap The Cartridge Gently. (Image 22)
An instructional illustration showing a hand holding a syringe containing a suspended injection. The syringe is held upright with gentle shaking indicated by motion lines, suggesting the mixture of suspension before use.*
FDA Label Image

Press The Push-button. (Image 23)

Press The Push-button. (Image 23)
An instructional illustration showing a hand holding an insulin pen with an arrow pointing upward, indicating a motion or step in using the pen. A smaller inset image shows a close-up of the pen's needle cap being removed or attached.*
FDA Label Image

Turn The Dose Selector. (Image 27)

Turn The Dose Selector. (Image 27)
An instructional illustration showing a close-up of a hand adjusting a dose selector on a pen injector device for Novolin 70/30 human insulin 100 IU/mL injection. The image demonstrates selecting doses of 5 units, 24 units, and dose ranges 4-6 units and 24-26 units, indicating incremental dose setting functionality.*
FDA Label Image

Exclamation Point. (Image 28)

Exclamation Point. (Image 28)
The image shows the packaging label for Novolin 70/30, a human insulin injection suspension for subcutaneous use. The label features the brand name Novolin 70/30 prominently at the top, with human insulin indicated as the active ingredient. The concentration is 100 IU/mL. The label includes product details such as dosage form and the labeler, A-S Medication Solutions. The packaging is primarily white and blue.*
FDA Label Image

Inject The Dose. (Image 29)

Inject The Dose. (Image 29)
An instructional illustration showing a hand pressing down on the cap of a Novolin 70/30 insulin injection pen to unlock or prepare it for use. The image includes an arrow indicating downward pressure and a close-up of a lock symbol with an unlocking motion.*
FDA Label Image

Keep The Needle In The Skin. (Image 30)

Keep The Needle In The Skin. (Image 30)
An instructional illustration showing the tip and needle area of a syringe or injection device, positioned for administration. The image highlights the detail of the needle and the beginning of the syringe barrel, suggesting preparation or injection usage for the product.*
FDA Label Image

Put The Pen Cap On Flexpen. (Image 31)

Put The Pen Cap On Flexpen. (Image 31)
An instructional illustration showing a close-up of a hand holding a syringe with a cap, indicating the removal of the cap by pulling it straight off, as shown by an arrow pointing upward.*
FDA Label Image

Exclamation Point. (Image 32)

Exclamation Point. (Image 32)
Novolin 70/30 Human Insulin 100 IU/mL injection suspension carton packaging. The label shows the product name, dosage form, strength, subcutaneous route, and the labeler A-S Medication Solutions. The image depicts a rectangular box with text and branding consistent with pharmaceutical insulin products.*
FDA Label Image

Exclamation Point. (Image 33)

Exclamation Point. (Image 33)
Novolin 70/30 Human Insulin Injection, Suspension 100 IU/mL in a 10 mL vial. The label shows the product name, concentration, route of administration (subcutaneous), and the labeler A-S Medication Solutions. The vial has a purple cap and an orange/red label background with black and white text.*
FDA Label Image

Exclamation Point. (Image 34)

Exclamation Point. (Image 34)
Novolin 70/30 Human Insulin 100 IU/mL injection, suspension in a vial. The label includes the product name, strength, dosage form, and the A-S Medication Solutions labeler information. The vial appears to be a small glass container with a white dispenser cap and a barcode section on the label.*
FDA Label Image

Exclamation Point. (Image 35)

Exclamation Point. (Image 35)
Novolin 70/30 Human Insulin 100 IU/mL injection suspension packaging label. The label shows product name, active ingredient, dosage strength, and volume (10 mL vial). The label also includes manufacturer information for A-S Medication Solutions and details such as lot number and expiration date areas.*
FDA Label Image

Exclamation Point. (Image 36)

Exclamation Point. (Image 36)
Novolin 70/30 injection, suspension vial with a white label and a red and gray cap. The label displays the product name Novolin 70/30, active ingredient Human Insulin, strength 100 IU/mL, and the A-S Medication Solutions logo. The vial is designed for subcutaneous use.*
FDA Label Image

Exclamation Point. (Image 37)

Exclamation Point. (Image 37)
Novolin 70/30 Human Insulin injection, suspension, 100 IU/mL in a multi-dose vial. The label shows drug concentration and vial dosage form, with A-S Medication Solutions as the labeler. The NDC 50090-0403 is also present on the label.*
FDA Label Image

Exclamation Point. (Image 38)

Exclamation Point. (Image 38)
Novolin 70/30 Human Insulin 100 IU/mL injection suspension vial label. The label shows the product name, strength, and dosage form. It is indicated for subcutaneous use and labeled by A-S Medication Solutions. The vial is amber-colored with a white and orange label highlighting the key product information.*
FDA Label Image

Exclamation Point. (Image 39)

Exclamation Point. (Image 39)
Novolin 70/30 Human Insulin 100 IU/mL injection, suspension vial label. The label displays the brand and generic name, strength, route of administration as subcutaneous, and the A-S Medication Solutions labeler. The vial contains a cloudy suspension indicated for injectable use.*
FDA Label Image

Exclamation Point. (Image 40)

Exclamation Point. (Image 40)
Novolin 70/30 Human Insulin injection, suspension in a vial. The label shows the product name Novolin 70/30 with human insulin as the active ingredient. The vial contains 100 units per milliliter. The labeler's name, A-S Medication Solutions, is visible, along with the product NDC 50090-0403.*
FDA Label Image

Label Image (Lbl500900403)

Label Image (Lbl500900403)
Label for Novolin 70/30 Human Insulin Injection, Suspension, 100 Units/mL in a 10 mL vial. The label indicates storage instructions to keep refrigerated until opened, not to freeze, and the labeler is A-S Medication Solutions, Libertyville, IL. The NDC number is 50090-0403.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.